Iterum Therapeutics plc
ITRM
|
|
|
|
Trading Volume | 2,945 |
|
2.30 - 0.65 |
Market Cap Full | $ 14.7M |
Quarterly +
2025 | 2024 | 2023 | 2022 | |
---|---|---|---|---|
Q1 | 8.6% | -20.3% | 19.1% | -10.5% |
Q2 | - | -26.1% | 7% | -43% |
Q3 | - | -5.8% | -22.4% | 710% |
Q4 | - | 43.6% | 149.4% | -48.2% |
Monthly +
J | F | M | A | M | J | J | A | S | O | N | D |
2025 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
8.6 | - | - | - | - | - | - | - | - | - | - | - |
2024 | |||||||||||
-21.8 | -19.5 | 26.6 | -8.9 | 4.9 | -20.7 | 0.8 | -5.8 | - | - | - | -11.4 |
2023 | |||||||||||
65.5 | -18 | -12.3 | 17 | -1.7 | -7 | -2.8 | -14.2 | -7 | -21.1 | 187 | 4.8 |
2022 | |||||||||||
-11.5 | 6.6 | -5.1 | -27.6 | -9.5 | -13 | 10 | 1100 | -38.6 | 4.3 | -23.1 | -35.4 |
2021 | |||||||||||
42.4 | 16.3 | -9.8 | -16.9 | 14.9 | 63.5 | -66.3 | -14 | -16.4 | -4.8 | -7.9 | -20.2 |
2020 | |||||||||||
-52.4 | 5.3 | 12.9 | 29.2 | 20.3 | -71.7 | -12.6 | -25 | 34.6 | -55.4 | 56.4 | 35.3 |
EPS
2023 | 2022 | 2021 | 2020 | |
---|---|---|---|---|
Q1 | -0.8 | -0.3 | -0.8 | -1.1 |
Q2 | -1 | -0.6 | 0 | -0.8 |
Q3 | -0.3 | -2.4 | 0 | -0.6 |
Q4 | 0 | -0.4 | 2.9 | 0.3 |
A | -2.03 | -3.6 | -8.4 | -32.5 |